253 related articles for article (PubMed ID: 32361310)
21. Generation of two ISL1-tdTomato reporter human induced pluripotent stem cell lines using CRISPR-Cas9 genome editing.
Tsukamoto S; Nakade K; Wakabayashi T; Nakashima K; Takami M; Hemmi Y; Kuramochi Y; Shimizu T; Arai Y; Matsuo-Takasaki M; Noguchi M; Nakamura Y; Miwa Y; Hayashi Y
Stem Cell Res; 2021 May; 53():102363. PubMed ID: 34087992
[TBL] [Abstract][Full Text] [Related]
22. Improved hematopoietic differentiation efficiency of gene-corrected beta-thalassemia induced pluripotent stem cells by CRISPR/Cas9 system.
Song B; Fan Y; He W; Zhu D; Niu X; Wang D; Ou Z; Luo M; Sun X
Stem Cells Dev; 2015 May; 24(9):1053-65. PubMed ID: 25517294
[TBL] [Abstract][Full Text] [Related]
23. The use of simultaneous reprogramming and gene correction to generate an osteogenesis imperfecta patient COL1A1 c. 3936 G>T iPSC line and an isogenic control iPSC line.
Howden S; Hosseini Far H; Motazedian A; Elefanty AG; Stanley EG; Lamandé SR; Bateman JF
Stem Cell Res; 2019 Jul; 38():101453. PubMed ID: 31082677
[TBL] [Abstract][Full Text] [Related]
24. CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors.
Jin Y; Shen Y; Su X; Weintraub N; Tang Y
J Vis Exp; 2019 Sep; (151):. PubMed ID: 31566614
[TBL] [Abstract][Full Text] [Related]
25. Generation of a homozygous ALX1 knockout human embryonic stem cell line (WAe001-A-060) by a CRISPR/Cas9 system.
Xiao X; Chen Y; Peng L; Zhang T
Stem Cell Res; 2021 May; 53():102309. PubMed ID: 33799274
[TBL] [Abstract][Full Text] [Related]
26. CRISPR-Cas9-Mediated Correction of the G189R-PAX2 Mutation in Induced Pluripotent Stem Cells from a Patient with Focal Segmental Glomerulosclerosis.
Trionfini P; Ciampi O; Todeschini M; Ascanelli C; Longaretti L; Perico L; Remuzzi G; Benigni A; Tomasoni S
CRISPR J; 2019 Apr; 2():108-120. PubMed ID: 30998089
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional landscape of a RET
Hadoux J; Desterke C; Féraud O; Guibert M; De Rose RF; Opolon P; Divers D; Gobbo E; Griscelli F; Schlumberger M; Bennaceur-Griscelli A; Turhan AG
Stem Cell Res; 2018 Jan; 26():8-16. PubMed ID: 29197744
[TBL] [Abstract][Full Text] [Related]
28. Generation of a heterozygous COL2A1 (p.G1113C) hypochondrogenesis mutation iPSC line, MCRIi019-A-7, using CRISPR/Cas9 gene editing.
Lilianty J; Bateman JF; Lamandé SR
Stem Cell Res; 2021 Oct; 56():102515. PubMed ID: 34543885
[TBL] [Abstract][Full Text] [Related]
29. CRISPR correction of the PRKAG2 gene mutation in the patient's induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalities.
Ben Jehuda R; Eisen B; Shemer Y; Mekies LN; Szantai A; Reiter I; Cui H; Guan K; Haron-Khun S; Freimark D; Sperling SR; Gherghiceanu M; Arad M; Binah O
Heart Rhythm; 2018 Feb; 15(2):267-276. PubMed ID: 28917552
[TBL] [Abstract][Full Text] [Related]
30. Generation of human induced pluripotential stem cells from individuals with complex heterozygous, isogenic corrected, and homozygous Bloc1s1 mutations.
Wu K; Takanohashi A; Woidill S; Seylani A; Helman G; Dias P; Beers J; Lin Y; Simons C; Wolvetang E; Zou J; Vanderver A; Sack MN
Stem Cell Res; 2022 Oct; 64():102905. PubMed ID: 36070637
[TBL] [Abstract][Full Text] [Related]
31. Generation of a DKK1 homozygous knockout human embryonic stem cell line WAe001-A-21 using CRISPR/Cas9.
Yang Z; Yuan F; Wang N; Liu Y; Zhang J; Wei R; Wu F; Wu Y; You K; Chen Y; Yang F; Li YX
Stem Cell Res; 2021 Mar; 51():102161. PubMed ID: 33461039
[TBL] [Abstract][Full Text] [Related]
32. Generation of a heterozygous COL2A1 (p.R989C) spondyloepiphyseal dysplasia congenita mutation iPSC line, MCRIi001-B, using CRISPR/Cas9 gene editing.
Lilianty J; Nur Patria Y; Stanley EG; Elefanty AG; Bateman JF; Lamandé SR
Stem Cell Res; 2020 May; 45():101843. PubMed ID: 32446218
[TBL] [Abstract][Full Text] [Related]
33. Modeling of dilated cardiomyopathy by establishment of isogenic human iPSC lines carrying phospholamban C25T (R9C) mutation (UPITTi002-A-1) using CRISPR/Cas9 editing.
Barndt RJ; Ma N; Tang Y; Haugh MP; Alamri LS; Chan SY; Wu H
Stem Cell Res; 2021 Oct; 56():102544. PubMed ID: 34583280
[TBL] [Abstract][Full Text] [Related]
34. Generation of a pluripotent stem cell line (UMGi270-A) and a corresponding CRISPR/Cas9 modified isogenic control (UMGi270-A-1) from a patient with sudden onset dilated cardiomyopathy harboring a FLNC p.R2187P mutation.
Maurer W; Rebs S; Köhne S; Eberl H; Wollnik B; Zibat A; Streckfuss-Bömeke K
Stem Cell Res; 2024 Jun; 77():103409. PubMed ID: 38583294
[TBL] [Abstract][Full Text] [Related]
35. Generation of two induced pluripotent stem cell lines (TMOi001-A-5, TMOi001-A-6) carrying variants in DISC1 exon 2 using CRISPR/Cas9 gene editing.
Heider J; Sperlich D; Vogel S; Breitmeyer R; Volkmer H
Stem Cell Res; 2022 Oct; 64():102925. PubMed ID: 36154917
[TBL] [Abstract][Full Text] [Related]
36. Generation of an induced pluripotent stem cell line from an Alström Syndrome patient with ALMS1 mutation (c.3902C > A, c.6436C > T) and a gene correction isogenic iPSC line.
Ji X; Tang Q; Tang C; Wu Z; Ma L; Guo X; Cheng G; Chen Y; Yang T; Xiong M; Zhou W
Stem Cell Res; 2020 Dec; 49():102089. PubMed ID: 33264725
[TBL] [Abstract][Full Text] [Related]
37. Generation of Human Isogenic Induced Pluripotent Stem Cell Lines with CRISPR Prime Editing.
Bonnycastle LL; Swift AJ; Mansell EC; Lee A; Winnicki E; Li ES; Robertson CC; Parsons VA; Huynh T; Krilow C; Mohlke KL; Erdos MR; Narisu N; Collins FS
CRISPR J; 2024 Feb; 7(1):53-67. PubMed ID: 38353623
[TBL] [Abstract][Full Text] [Related]
38. Simplified Footprint-Free Cas9/CRISPR Editing of Cardiac-Associated Genes in Human Pluripotent Stem Cells.
Kondrashov A; Duc Hoang M; Smith JGW; Bhagwan JR; Duncan G; Mosqueira D; Munoz MB; Vo NTN; Denning C
Stem Cells Dev; 2018 Mar; 27(6):391-404. PubMed ID: 29402189
[TBL] [Abstract][Full Text] [Related]
39. Pathogenic mechanism and gene correction for LQTS-causing double mutations in KCNQ1 using a pluripotent stem cell model.
Wang Z; Wang L; Liu W; Hu D; Gao Y; Ge Q; Liu X; Li L; Wang Y; Wang S; Li C
Stem Cell Res; 2019 Jul; 38():101483. PubMed ID: 31226583
[TBL] [Abstract][Full Text] [Related]
40. Generation of a ST3GAL3 null mutant induced pluripotent stem cell (iPSC) line (UKWMPi002-A-3) by CRISPR/Cas9 genome editing.
Diouf D; Vitale MR; Zöller JEM; Pineau AM; Klopocki E; Hamann C; Ziegler GC; Vanmierlo T; Van den Hove D; Lesch KP
Stem Cell Res; 2023 Mar; 67():103038. PubMed ID: 36746102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
